BCL2A1 and squamous cell carcinoma of penis: In brief, the BCL2A1 protein was detected in 154 of 220 (70.0%) PSCC patients, 72 of whom (32.7%) had high expression (IHC score >2), while 148 (67.3%) had low expression.